tiprankstipranks
Advertisement
Advertisement

AU:CHM Stock Latest News

Chimeric Therapeutics to List 733,333 New Shares on ASX
Company AnnouncementsChimeric Therapeutics to List 733,333 New Shares on ASX
2d ago
CHM
Chimeric Therapeutics Issues Unquoted Convertible Note Warrants
PremiumCompany Announcements
Chimeric Therapeutics Issues Unquoted Convertible Note Warrants
3d ago
CHM
Chimeric Therapeutics Issues New Unquoted Options and Convertible Notes
PremiumCompany Announcements
Chimeric Therapeutics Issues New Unquoted Options and Convertible Notes
3d ago
CHM
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
PremiumCompany Announcements
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
4d ago
CHM
Chimeric Therapeutics Finalises ASX Security Consolidation
PremiumCompany Announcements
Chimeric Therapeutics Finalises ASX Security Consolidation
5d ago
CHM
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
PremiumCompany AnnouncementsChimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
16d ago
CHM
Chimeric Therapeutics Wins Shareholder Backing for Capital Restructuring at EGM
Premium
Company Announcements
Chimeric Therapeutics Wins Shareholder Backing for Capital Restructuring at EGM
16d ago
CHM
Chimeric Therapeutics Flags Risks Around Forward-Looking Cell Therapy Statements
Premium
Company Announcements
Chimeric Therapeutics Flags Risks Around Forward-Looking Cell Therapy Statements
1M ago
CHM
Chimeric Therapeutics to Showcase Cancer Cell Therapy Pipeline at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Chimeric Therapeutics to Showcase Cancer Cell Therapy Pipeline at NWR Virtual Healthcare Conference
1M ago
CHM
Chimeric Therapeutics Launches Complex Capital Raising via Prospectus
PremiumCompany Announcements
Chimeric Therapeutics Launches Complex Capital Raising via Prospectus
1M ago
CHM
Chimeric Therapeutics Restructures Warrant Issue With Unchanged Total Value
PremiumCompany Announcements
Chimeric Therapeutics Restructures Warrant Issue With Unchanged Total Value
2M ago
CHM
Chimeric Therapeutics to Consolidate Shares and Equity Securities
PremiumCompany Announcements
Chimeric Therapeutics to Consolidate Shares and Equity Securities
2M ago
CHM
Chimeric Therapeutics Sets Hybrid Extraordinary General Meeting for April 2026
PremiumCompany AnnouncementsChimeric Therapeutics Sets Hybrid Extraordinary General Meeting for April 2026
2M ago
CHM
Chimeric’s New Chair Refocuses Strategy Around Lead GI Cancer Cell Therapy
Premium
Company Announcements
Chimeric’s New Chair Refocuses Strategy Around Lead GI Cancer Cell Therapy
2M ago
CHM
Chimeric Therapeutics Secures $1.8m Advance on FY26 R&D Tax Incentive
Premium
Company Announcements
Chimeric Therapeutics Secures $1.8m Advance on FY26 R&D Tax Incentive
2M ago
CHM
Chimeric Therapeutics Posts Wider Half-Year Loss as Auditor Flags Going Concern Risk
PremiumCompany Announcements
Chimeric Therapeutics Posts Wider Half-Year Loss as Auditor Flags Going Concern Risk
2M ago
CHM
Chimeric Hands Back CHM CLTX to City of Hope to Sharpen Focus on Core Cell Therapy Programs
PremiumCompany Announcements
Chimeric Hands Back CHM CLTX to City of Hope to Sharpen Focus on Core Cell Therapy Programs
2M ago
CHM
Chimeric Clarifies ASX Query on CORE NK Trial Disclosures
PremiumCompany Announcements
Chimeric Clarifies ASX Query on CORE NK Trial Disclosures
2M ago
CHM
Chimeric Therapeutics Revises Terms and Timing of Convertible Note Issue
PremiumCompany Announcements
Chimeric Therapeutics Revises Terms and Timing of Convertible Note Issue
2M ago
CHM
Chimeric Therapeutics Secures Funding to Complete Phase 1 CAR‑T Trial and Launches Strategic Reset
PremiumCompany AnnouncementsChimeric Therapeutics Secures Funding to Complete Phase 1 CAR‑T Trial and Launches Strategic Reset
2M ago
CHM
Chimeric Therapeutics Posts Strong CDH17 CAR‑T Data and Gains FDA Orphan Status for Gastric Cancer
Premium
Company Announcements
Chimeric Therapeutics Posts Strong CDH17 CAR‑T Data and Gains FDA Orphan Status for Gastric Cancer
3M ago
CHM
Chimeric Therapeutics Issues 309.9 Million New Shares Under Regulatory Notice
Premium
Company Announcements
Chimeric Therapeutics Issues 309.9 Million New Shares Under Regulatory Notice
4M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >